Researchers Use fMRI to Examine Neuroplasticity in Dysphagia Caused by PD
January 6th 2022Researchers sought to examine the effect on corresponding regions of the brain after patients with Parkinson disease (PD) and swallowing problems underwent functional magnetic resonance imaging (fMRI) after receiving 10 sessions of repetitive transcranial magnetic stimulation.
Read More
Dr Steven Pergam Explains NCCN COVID-19 Update
January 5th 2022Steven Pergam, MD, MPH, director of infection prevention at Seattle Cancer Care Alliance and infectious disease physician at Fred Hutchinson Cancer Research Center, explains the National Comprehensive Cancer Network (NCCN) update on COVID-19 vaccines and prevention.
Watch
The Biden administration doubled its order of Pfizer’s COVID-19 antiviral drug; California is now the first state to require health insurance plans to cover at-home STI tests; the Supreme Court will hear in-person arguments Friday to decide whether to block federal vaccine mandates.
Read More
Anthony Fauci, MD, said the CDC is considering changes to its guidance requiring a negative COVID-19 test after 5-day quarantine; bipartisan legislation banning surprise medical billing goes into effect; booster vaccine programs may be limiting global vaccine supply for low- and middle-income countries.
Read More
ACCC Presents Survey Responses on Adoption of Bispecific Antibodies
January 2nd 2022ACCC created a survey to better understand multidisciplinary cancer providers’ experiences with bispecific antibodies, with a focus on experiences with blinatumomab. Results of the survey were presented in an abstract during the 2021 American Society of Hematology Annual Meeting & Exposition.
Read More
Study Expands Evidence of Inheritance Pattern in GDF2 Associated With PAH
January 2nd 2022Study results regarding the clinical spectrum and inheritance pattern of GDF2 pathogenic variants suggest incomplete penetrance and/or variability of expressivity with a semi-dominant pattern of inheritance in the context of PAH.
Read More
Ponatinib, High-Dose Chemo Combo Likely to Benefit High-risk BP-CML
January 1st 2022Survival rates for patients with blast-phase chronic myeloid leukemia (BP-CML) are notoriously poor, necessitating effective treatments to fill the care gap for this group who often survive less than 1 year.
Read More